Disclaimer: Whilst we always aim to provide accurate information, Recite Me uses machine translation so the translation may not be perfect and we can’t guarantee its accuracy. Myeloma UK accepts no liability for any inaccuracies resulting from the use of this translation tool. The information provided is not meant to replace the advice of your healthcare team. Find out more about this tool at reciteme.com
This meeting will deliver key clinical data from the recent ASH Annual Meeting that are applicable to UK haematology practice. The session of particular interest for myeloma clinicians runs on Day 2 (Wednesday):
Myeloma Session
Chair: Dr Rakesh Popat, University College London Hospitals.
14:05 Up-front myeloma – Dr Sally Moore, University Hospitals Bristol.
14:35 Relapsed/refractory myeloma – Dr Rakesh Popat.
15:05 Panel discussion.
For HCPs specialising in myeloma, this is a good opportunity to hear from UK-based experts about first-line and relapsed/refractory myeloma updates from ASH with relevance to UK clinical practice.
–
